Mostrando 6 resultados de: 6
Filtros aplicados
Publisher
AAPS Advances in the Pharmaceutical Sciences Series(1)
Applied Sciences (Switzerland)(1)
Cancers(1)
Journal of Nanobiotechnology(1)
Nanomedicine(1)
Área temáticas
Farmacología y terapéutica(6)
Enfermedades(4)
Medicina y salud(2)
Fisiología y materias afines(1)
Física aplicada(1)
Área de conocimiento
Biomedicina(2)
Bioquímica(1)
Biotecnología(1)
Ciencia de materiales(1)
Farmacología(1)
Origen
scopus(6)
Epigallocatechin-3-gallate PEGylated poly(lactic-co-glycolic) acid nanoparticles mitigate striatal pathology and motor deficits in 3-nitropropionic acid intoxicated mice
ArticleAbstract: Aim: To compare free and nanoparticle (NP)-encapsulated epigallocatechin-3-gallate (EGCG) for the trPalabras claves:3-nitropropionic acid, Epigallocatechin-3-gallate, Huntington's disease, neurodegenerative diseases, PLGA-PEG, Polymeric nanoparticlesAutores:Antoni Camins, Auladell C., Barenys M., Cano A., Espina M., Ettcheto M., Folch J., García M.L., Kühne B.A., Sanchez-Lopez E., Souto E.M.B., Turowski P.Fuentes:scopusNanomedicine-based technologies and novel biomarkers for the diagnosis and treatment of Alzheimer’s disease: from current to future challenges
ReviewAbstract: Increasing life expectancy has led to an aging population, which has consequently increased the prevPalabras claves:Alzheimer’s disease, Biomarkers, lipid nanoparticles, Metal nanoparticles, nanotechnology, Polymeric nanoparticlesAutores:Antoni Camins, Boada M., Cano A., Duskey J.T., Ettcheto M., García M.L., Marquié M., Ruiz A., Sanchez-Lopez E., Souto E.M.B., Tosi G., Turowski P.Fuentes:scopusNanoparticle Products for the Eye: Preformulation, Formulation, and Manufacturing Considerations
Book PartAbstract: Recent developments in nanotechnology have provided an unprecedented opportunity to improve the prevPalabras claves:lipid nanoparticles, Nanoparticles, Ocular drug delivery, PLGA nanoparticles, Polymeric nanoparticlesAutores:Antoni Camins, Cano A., Espina M., Ettcheto M., García M.L., Sanchez-Lopez E., Souto E.M.B.Fuentes:scopusLipid nanocarriers for hyperproliferative skin diseases
ReviewAbstract: Hyperproliferative skin diseases (HSD) are a group of diseases that include cancers, pre-cancerous lPalabras claves:Antiproliferative drugs, Hyperproliferative skin diseases, lipid nanoparticles, Liposomes, Skin cancerAutores:Cano A., Chorilli M., de Souza A.L.R., Gremião M.P.D., Karczewski J., Kolenyak Fernanda Dos Santos, Sanchez-Lopez E., Souto E.M.B., Staszewski R., Zielińska A.Fuentes:scopusState of the art on toxicological mechanisms of metal and metal oxide nanoparticles and strategies to reduce toxicological risks
ReviewAbstract: Metal nanoparticles have been extensively investigated for different types of pharmaceutical applicaPalabras claves:Metal nanoparticles, Nanoparticles functionalization, Nanoparticles toxicity, Reactive oxygen speciesAutores:Antoni Camins, Barroso E., Cano A., Espina M., Ettcheto M., García M.L., García-Torra V., Sanchez-Lopez E., Souto E.M.B., Vázquez-Carrera M.Fuentes:scopusSurface functionalization of plga nanoparticles to increase transport across the bbb for alzheimer’s disease
ReviewAbstract: Alzheimer’s disease (AD) is a chronic neurodegenerative disorder that accounts for about 60% of allPalabras claves:Alzheimer’s disease, blood-brain barrier, Brain delivery, Functionalized PLGA nanoparticlesAutores:Amo L.D., Antoni Camins, Cano A., Espina M., Ettcheto M., García M.L., Sanchez-Lopez E., Souto E.M.B.Fuentes:scopus